Table 1.

Expression Levels of 20 miRNAs in Cancer Samples Compared with Those in Normal Controls by Paired t-Test. Compared with the Adjacent Normal Samples, in the Cancer Tissues, 7 of the 20 Selected miRNAs Were Significantly Dysregulated (P<0.05), and Were Likely to Be Good Candidates as Diagnostic Biomarkers. The Fold Changes in All the Dysregulated miRNAs Were Greater Than 2-Fold, Upregulated or Downregulated. Furthermore, miR-145 Demonstrated the Greatest Change at More Than 16-Fold

miRNA	ΔΔCt	2^-ΔΔCt	Fold Change	P-value	miRNA	ΔΔCt	2^-ΔΔCt	Fold Change	P-value
miR-145	4.010	0.062	−16.111	<0.001	miR-15a	0.117	0.922	−1.085	0.763
miR-23b	2.245	0.211	−4.740	<0.001	miR-489	−0.089	1.064	1.064	0.878
miR-204	1.598	0.330	−3.027	0.000	miR-425	−0.178	1.131	1.131	0.700
miR-195	1.398	0.379	−2.635	0.002	miR-216a	−0.248	1.188	1.188	0.702
miR-23a	1.352	0.392	−2.553	0.002	miR-200b	−0.306	1.236	1.236	0.523
miR-497	1.133	0.456	−2.193	0.018	miR-424	−0.360	1.284	1.284	0.351
miR-23c	0.838	0.559	−1.788	0.128	miR-200c	−0.400	1.320	1.320	0.320
miR-15b	0.655	0.635	−1.574	0.136	miR-503	−0.527	1.441	1.441	0.127
miR-16	0.373	0.772	−1.295	0.352	miR-211	−0.531	1.445	1.445	0.544
miR-216b	0.246	0.843	−1.186	0.652	miR-429	−1.825	3.543	3.543	<0.001